Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
Eli Lilly and Company's top products based on revenue in 2022 and 2023 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Eli Lilly
Market overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2024
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
- Premium Statistic World's most valuable pharmaceutical brands 2023 by brand value
Key figures
5
Business distribution
3
Competitors
4
Research and development
5
- Premium Statistic Total global pharmaceutical R&D spending 2014-2028
- Basic Statistic Eli Lilly's research and development expenditure 2007-2023
- Basic Statistic Eli Lilly's R&D expenditure as a share of revenue 2010-2023
- Premium Statistic Top pharma companies worldwide 2024, by size of R&D pipeline
- Basic Statistic Projected most valuable R&D projects based on net present value 2023
Further related statistics
17
- Number of pharmaceuticals on China's national reimbursement drug list
- Boehringer Ingelheim's top self-medication drugs revenues 2008-2016
- Eli Lilly's total revenue per employee 2013-2019
- Eli Lilly capital expenditures 2013-2023
- U.S. human and veterinary pharmaceuticals - R&D spending 2017
- Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Number of approved ANDAs in U.S. FY 2009-2023
- Top specialty drug pharmacies in the U.S. by revenue 2023
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Number of ANDA approvals in U.S. 2015-2017, by type
- Gilead Sciences' top products based on revenue 2021-2023
- Patent applications for genetic drugs worldwide 2010
- Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Top specialty drug pharmacies in the U.S. based on market share 2023
- Volume of exports of Chinese medicinal plants from China H1 2020, by ingredients
- Leading immunostimulant brands in Russia Q1 2020, by sales share
Further Content: You might find this interesting as well
Statistics
- Number of pharmaceuticals on China's national reimbursement drug list
- Boehringer Ingelheim's top self-medication drugs revenues 2008-2016
- Eli Lilly's total revenue per employee 2013-2019
- Eli Lilly capital expenditures 2013-2023
- U.S. human and veterinary pharmaceuticals - R&D spending 2017
- Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Number of approved ANDAs in U.S. FY 2009-2023
- Top specialty drug pharmacies in the U.S. by revenue 2023
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Number of ANDA approvals in U.S. 2015-2017, by type
- Gilead Sciences' top products based on revenue 2021-2023
- Patent applications for genetic drugs worldwide 2010
- Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Top specialty drug pharmacies in the U.S. based on market share 2023
- Volume of exports of Chinese medicinal plants from China H1 2020, by ingredients
- Leading immunostimulant brands in Russia Q1 2020, by sales share
Eli Lilly and Company. (February 23, 2024). Eli Lilly and Company's top products based on revenue in 2022 and 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/statistics/278214/eli-lilly-and-companys-top-products-based-on-revenue/
Eli Lilly and Company. "Eli Lilly and Company's top products based on revenue in 2022 and 2023 (in million U.S. dollars)." Chart. February 23, 2024. Statista. Accessed May 11, 2024. https://www.statista.com/statistics/278214/eli-lilly-and-companys-top-products-based-on-revenue/
Eli Lilly and Company. (2024). Eli Lilly and Company's top products based on revenue in 2022 and 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/statistics/278214/eli-lilly-and-companys-top-products-based-on-revenue/
Eli Lilly and Company. "Eli Lilly and Company's Top Products Based on Revenue in 2022 and 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 23 Feb 2024, https://www.statista.com/statistics/278214/eli-lilly-and-companys-top-products-based-on-revenue/
Eli Lilly and Company, Eli Lilly and Company's top products based on revenue in 2022 and 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/278214/eli-lilly-and-companys-top-products-based-on-revenue/ (last visited May 11, 2024)
Eli Lilly and Company's top products based on revenue in 2022 and 2023 (in million U.S. dollars) [Graph], Eli Lilly and Company, February 23, 2024. [Online]. Available: https://www.statista.com/statistics/278214/eli-lilly-and-companys-top-products-based-on-revenue/